Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Packaging | | Medicap Healthcare Share Price
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Packaging | | Medicap Healthcare Share Price
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Sales | 71.60 | 102.11 | 108.30 |
| Operating Expenses ⓘ + | 48.93 | 66.43 | 71.15 |
| Operating Profit ⓘ | 22.67 | 35.68 | 37.16 |
| Operating Profit Margin (%) | 31.7% | 34.9% | 34.3% |
| Other Income ⓘ + | 1.01 | 0.94 | 1.60 |
| Interest ⓘ | 0.36 | 0.69 | 1.48 |
| Depreciation ⓘ | 3.47 | 3.85 | 4.50 |
| Profit Before Tax ⓘ | 19.84 | 32.08 | 35.33 |
| Tax ⓘ | 5.06 | 8.19 | 8.72 |
| Profit After Tax | 14.79 | 23.90 | 26.62 |
| PAT Margin (%) | 20.7% | 23.4% | 24.6% |
| Adjusted EPS (₹) | 6.0 | 9.8 | 10.9 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 60.32 | 84.21 | 110.84 | ||||||||
| Debt + | 26.54 | 6.79 | 82.12 | ||||||||
| Minority Interest | 0 | 0 | 0.01 | ||||||||
| Trade Payables | 5.64 | 6.89 | 4.54 | ||||||||
| Others Liabilities ⓘ | 5.85 | 8.02 | 18.76 | ||||||||
| Total Liabilities ⓘ | 98.35 | 105.89 | 216.27 | ||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 42.30 | 45.42 | 92.77 | ||||||||
| CWIP ⓘ | 0.21 | 0.17 | 28.55 | ||||||||
| Investments ⓘ | 0 | 0 | 0 | ||||||||
| Inventories | 18.50 | 16.32 | 18.25 | ||||||||
| Trade Receivables | 19.72 | 26.96 | 31.65 | ||||||||
| Cash Equivalents | 7.22 | 7.95 | 14.08 | ||||||||
| Others Assets ⓘ | 10.40 | 9.07 | 30.97 | ||||||||
| Total Assets ⓘ | 98.35 | 105.89 | 216.27 | ||||||||
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 9.93 | 25.21 | 23.86 |
| Cash Flow From Investing Activity ⓘ + | -6.24 | -4.38 | -96.38 |
| Cash Flow From Financing Activity ⓘ + | -4.71 | -20.43 | 78.20 |
| Net Cash Flow ⓘ | -1.02 | 0.40 | 5.68 |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 24.52 | 33.07 | 27.29 | |||||||
| ROCE (%) | 23.2 | 36.76 | 25.38 | |||||||
| Asset Turnover Ratio | 0.73 | 1 | 0.68 | |||||||
| PAT to CFO Conversion(x) | 0.67 | 1.05 | 0.9 | |||||||
| Working Capital Days | ||||||||||
| Receivable Days | 100 | 83.10 | 98 | |||||||
| Inventory Days | 93.80 | 62 | 57.80 | |||||||
| Payable Days | 62.40 | 49.80 | 44.50 | |||||||

